InspireMD- Warrants Profit Margin

The latest profit margin for NSPRZ is -355.17% as of June 2026. That compares with -303.69% in the prior-year period — down 17.0% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside InspireMD- Warrants's historical trend and sector peers before judging valuation or financial health.

Over the past year, NSPRZ's profit margin moved from -303.69% to -355.17% — a 17.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InspireMD- Warrants's valuation or profitability profile.

Against Healthcare companies, NSPRZ currently prints -355.17% for profit margin, while the sector average sits near 19.13%. That is roughly 1956.5% below the sector mean. Large gaps often invite a closer look at InspireMD- Warrants's growth, margins, and balance sheet.

Profit Margin shows how effectively InspireMD- Warrants converts resources into returns. At -355.17%, NSPRZ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -303.69% in the prior-year period — down 17.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NSPRZ's profit margin (-355.17%), review year-over-year change from -303.69%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.